Position in ETON
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$584,702
+$407,604 QoQ
Shares Held
16,152
+54.2% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 163 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in ETON Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Man Group plc holds $452,779,482 across 30 Drug Manufacturers - Specialty & Generic names. ETON ranks #22 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,805,003 | $129,707,515 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
601,019 | $101,295,742 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
134,890 | $73,087,447 | |
| 4 | VTRS |
Viatris Inc
|
3,523,052 | $55,946,065 | |
| 5 | PRGO |
PERRIGO Co plc
|
1,530,206 | $15,898,840 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
732,867 | $7,328,670 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
156,422 | $7,275,186 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
1,451,781 | $7,157,279 |
All Filings in ETON
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $584,702 | 16,152 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $177,098 | 10,473 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $274,862 | 12,649 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $338,494 | 23,754 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $290,803 | 22,404 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||